Q3 2025 SI-BONE Inc Earnings Call Transcript
Key Points
- SI-BONE Inc (SIBN) reported a robust revenue growth of approximately 21% in the third quarter, reaching $48.7 million.
- The company achieved sustained adjusted EBITDA profitability with a positive adjusted EBITDA of $2.3 million, translating to an adjusted EBITDA margin of approximately 5%.
- SI-BONE Inc (SIBN) successfully commercialized iFuse-TORQ in Europe and made significant progress on two new products expected to launch in 2026.
- The company experienced a notable increase in international revenue growth, fueled by the launch of iFuse-TORQ.
- SI-BONE Inc (SIBN) achieved its first quarter of meaningful positive cash flow from operating activities, marking a significant milestone in its financial performance.
- Despite the positive financial performance, SI-BONE Inc (SIBN) reported a net loss of $4.6 million or $0.11 per diluted share.
- Operating expenses increased by $4.7 million or 11.9%, reflecting growth-related investments and higher commissions.
- The company anticipates using some cash in the fourth quarter to build up surgical capacity and prepare for new product launches.
- Gross margin, while expanding, is expected to stabilize around 78% to 78.5% in the medium term, which may be lower than current levels due to new product launches.
- The company faces a challenging competitive landscape, particularly in expanding its interventional business, which requires significant investment in physician engagement and training.
Good afternoon, and welcome to SI-BONE's third-quarter 2025 earnings conference call (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I'll now turn the call over to Saqib Iqbal, Vice President, FP&A, Investor Relations at SI-BONE for a few introductory comments. Please go ahead.
Earlier today, SI-BONE released financial results for the quarter ended September 30, 2025. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that, management's remarks today may include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are subject to a number of risks and uncertainties, including those set forth in our SEC filings, such as our most recent Form 10-K, and actual results may differ materially from any forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
